Clinical Roundup First patient enrolls in MMRF’s Horizon Two clinical trial for newly diagnosed multiple myeloma treatment July 02, 2026Vol.52 No.26
Clinical Roundup Canine osteosarcoma data highlights growing role of comparative oncology July 02, 2026Vol.52 No.26
Clinical Roundup High patient volume is the leading driver of burnout in cancer and infusion centers, LeanTaaS’s “State of Cancer Centers” 2026 report finds July 02, 2026Vol.52 No.26
Drugs & Targets FDA approved 17 new cancer treatments in 2025, OCE annual report states July 02, 2026Vol.52 No.26
Drugs & Targets FDA approves expanded use of Casgevy for pediatric sickle cell disease or transfusion-dependent beta thalassemia July 02, 2026Vol.52 No.26
Regulatory News To keep the early clinical trial enterprise in the U.S., HHS pledges to simplify regulatory requirements June 26, 2026Vol.52 No.25By Paul Goldberg
Cancer Policy FDA advisory panel recommends first-of-its-kind mRNA flu vaccine for older adults June 26, 2026Vol.52 No.25By Claire Marie Porter
